Stock · NSE

ALKEM

5,669.50▲ 21.00 (0.37%)

Last 2 days · 15m candles10/7/2026, 22:32:11

Open: 5,645.00High: 5,720.00Low: 5,638.00Prev: 5,648.50

Positive

Neutral

Negative

News mentioning ALKEM

Sentiment: 0%← All news

VERIFIEDET Finance·17d★ ON YOUR LIST

Indian pharma firms gear up to supply key cancer drug to US

AI summary· NEUTRAL

·Indian drugmakers are preparing to supply ifosfamide injection to the US.
·Zydus, Cipla, Alkem, and Aurobindo Pharma are in discussions to provide the chemotherapy drug.
·The US FDA has contacted Indian pharmaceutical bodies to find manufacturers for the drug.

CIPLA AUROPHARMA ALKEM ZYDUSLIFE

VERIFIEDMint Markets·32d★ ON YOUR LIST

Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a row

AI summary· NEUTRAL

SUNPHARMA NIFTY NIFTYPHARMA ALKEM

VERIFIEDET Markets·37d★ ON YOUR LIST

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal

AI summary· NEUTRAL

·Block deals worth Rs 930 crore involving 17.88 lakh Alkem Laboratories shares occurred at Rs 5,200 each.
·Promoter-linked entities sold their stake, while domestic mutual funds and foreign institutional investors bought shares.
·Alkem Laboratories launched semaglutide pre-filled syringes in India.

ALKEM

VERIFIEDET Stocks·37d★ ON YOUR LIST

Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani Ports

AI summary· NEUTRAL

·Nifty showed signs of recovery but faced resistance around 23,800-24,000.
·Alkem Labs, Vedanta, Canara Bank, NHPC, and Adani Ports are in focus due to corporate developments.
·Developments include block deals, ED visits, capital raising, oversubscribed OFS, and strong cargo volumes.

ADANIPORTS CANBK VEDL NIFTY ALKEM

VERIFIEDET Stocks·38d★ ON YOUR LIST

Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers

AI summary· NEUTRAL

·Alkem Laboratories saw block deals worth Rs 930 crore.
·Promoter family entities sold shares to domestic mutual funds and foreign institutional investors.
·The transaction follows a strong performance by Alkem Laboratories shares in the past year.

ALKEM

VERIFIEDET Markets·38d★ ON YOUR LIST

Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers

AI summary· NEUTRAL

·Alkem Laboratories saw block deals worth Rs 930 crore.
·Promoter family entities sold shares to domestic mutual funds and foreign institutional investors.
·The transaction follows a strong performance by Alkem Laboratories shares in the past year.

ALKEM

VERIFIEDET Finance·38d★ ON YOUR LIST

Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss

AI summary· NEUTRAL

·Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India.
·The product is priced at Rs 350 and is intended for diabetes and weight loss management.
·Alkem is the first company in India to offer semaglutide in this pre-filled syringe format.

ALKEM

REFERENCEGoogle News, NIFTY/SENSEX·38d★ ON YOUR LIST

Sensex Today | Stock Market Live: Sensex, Nifty down at pre-open; Hero Moto, Alkem Labs, NHPC, Equitas SFB in focus - Moneycontrol.com

NIFTY SENSEX ALKEM HEROMOTOCO

REFERENCEGoogle News, NIFTY/SENSEX·38d★ ON YOUR LIST

Sensex Today | Stock Market LIVE Updates: Alkem Labs sees shares worth ₹930 crore change hands in large trade - CNBC TV18

SENSEX ALKEM

REFERENCEGoogle News, India stocks·38d★ ON YOUR LIST

Sensex Today | Stock Market Live: GIFT Nifty signals a negative opening; Hero Moto, Alkem Labs, NHPC, Equitas SFB in focus - Moneycontrol.com

NIFTY SENSEX ALKEM HEROMOTOCO